These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 23273163)
1. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma. Dissanayake S; Grothe B; Kaiser K Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163 [TBL] [Abstract][Full Text] [Related]
2. Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma. Price D; Hillyer EV Expert Rev Respir Med; 2014 Jun; 8(3):275-91. PubMed ID: 24802285 [TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice. Tamm M; Richards DH; Beghé B; Fabbri L Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma. Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations. Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial. Bodzenta-Lukaszyk A; van Noord J; Schröder-Babo W; McAulay K; McIver T Curr Med Res Opin; 2013 May; 29(5):579-88. PubMed ID: 23368897 [TBL] [Abstract][Full Text] [Related]
7. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study. Aalbers R; Brusselle G; McIver T; Grothe B; Bodzenta-Lukaszyk A Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745 [TBL] [Abstract][Full Text] [Related]
8. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C; Wu EQ; Ray S; Colice GL Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019 [TBL] [Abstract][Full Text] [Related]
10. [A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma]. Devillier P; Salvator H; Grassin-Delyle S; Naline E; Advenier C; Roche N Rev Mal Respir; 2014 Oct; 31(8):700-13. PubMed ID: 25391505 [TBL] [Abstract][Full Text] [Related]
11. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189 [TBL] [Abstract][Full Text] [Related]
12. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566 [TBL] [Abstract][Full Text] [Related]
14. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. Bodzenta-Lukaszyk A; Dymek A; McAulay K; Mansikka H BMC Pulm Med; 2011 May; 11():28. PubMed ID: 21605396 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy in asthma--fixed or variable dosing in different patients? Lötvall J Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472 [TBL] [Abstract][Full Text] [Related]
16. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma. Pearlman DS; LaForce CF; Kaiser K Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606 [TBL] [Abstract][Full Text] [Related]
17. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Blais L; Beauchesne MF; Forget A Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647 [TBL] [Abstract][Full Text] [Related]
18. Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma. Tan RA; Corren J Drug Des Devel Ther; 2014; 8():1555-61. PubMed ID: 25328383 [TBL] [Abstract][Full Text] [Related]
19. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma. Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703 [TBL] [Abstract][Full Text] [Related]
20. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]